Cargando…
Should we shift warfarin to non-vitamin K antagonist oral anticoagulants for patients with atrial fibrillation staying well on warfarin for years?
FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: Non-vitamin K antagonist oral anticoagulants (NOACs) are recommended over warfarin for stroke prevention for patients with atrial fibrillation (AF) in 2020 ESC guidelines. However, whether warfarin should be shifted to NOACs for pa...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207235/ http://dx.doi.org/10.1093/europace/euad122.203 |